Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japanese companies may present applications in person:

This article was originally published in Clinica

Executive Summary

Japanese companies filing for product approvals are to be permitted to present their products and associated data to the licensing authorities in person, under a new move designed to curtail the sometimes lengthy approval process. Questions and answers on a product may flow to and fro between authority and applicant, the licensing authorities sometimes needing explicit explanations on new technologies. The person-to-person approach may offer a short cut, with each company able to present for 30 minutes and then be expected to respond to questions for a similar length of time. Prefectural governments were informed of the new application filing method in March.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT071216

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel